Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.56 USD | -1.15% | +5.65% | +68.42% |
10/05 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
09/05 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+68.42% | 1.75B | |
+40.47% | 54.04B | |
+45.77% | 41.96B | |
-1.86% | 41.92B | |
-7.20% | 28.35B | |
+11.53% | 26.35B | |
-21.71% | 19B | |
+4.87% | 13B | |
+29.12% | 12.28B | |
+25.41% | 12.19B |
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- Goldman Sachs Starts Edgewise Therapeutics at Neutral With $11 Price Target